Literature DB >> 26849883

Subclinical pulmonary abnormalities in childhood-onset systemic lupus erythematosus patients.

C S Veiga1, D S Coutinho2, C M A Nakaie2, L M A Campos3, L Suzuki4, M T Cunha5, C Leone6, C A Silva3, J C Rodrigues2.   

Abstract

OBJECTIVE: The aims of this study were to analyze the pulmonary function of childhood-onset systemic lupus erythematosus (cSLE) patients and to identify possible correlations between the high-resolution computed chest tomography (HRCT) score, disease activity, disease cumulative damage, and the participants' quality of life.
METHODS: Forty cSLE patients, median age: 14.1 years (range: 7.4-17.9), underwent spirometry and plethysmography. Carbon monoxide diffusing capacity (DLCO), HRCT, disease activity, disease cumulative damage, and quality of life were assessed.
RESULTS: Pulmonary abnormalities were evident in 19/40 (47.5%) cSLE patients according to spirometry/DLCO. Forced expired volume in one second (FEV1%) was the parameter most affected (30%). The HRCT showed some abnormality in 22/30 patients (73%), which were minimal in 43%. Signs of airway affects were found in 50%. Twelve patients were hospitalized due to cSLE-related pulmonary complications before the study began (median discharge: 2.1 years earlier). Total lung capacity (TLC%), vital capacity (VC%), forced vital capacity (FVC%), and FEV1% were significantly lower in the group with hospitalization compared to the group without hospitalization (p = 0.0025, p = 0.0022, p = 0.0032, and p = 0.0004, respectively). Of note, DLCO was positively correlated with disease duration (r = +0.4; p = 0.01). The HRCT-score was negatively correlated with FEV1/VC (r = -0.63; p = 0.0002), FEV1 (r = -0.54; p = 0.018), FEF25%-75% (r = -0.67; p < 0.0001), and HRCT-score was positively correlated with resistance (r = +0.49; p = 0.0056).
CONCLUSIONS: Almost half of patients with cSLE had subclinical pulmonary abnormalities, especially airway abnormalities. The cSLE-related pulmonary complications seem to determine long-term functional damage.
© The Author(s) 2016.

Entities:  

Keywords:  Systemic lupus erythematosus; anti-DNA antibodies; vasculitis

Mesh:

Substances:

Year:  2016        PMID: 26849883     DOI: 10.1177/0961203316629554

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  3 in total

1.  Subclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifestations.

Authors:  Pedro Anuardo; Monica Verdier; Natali W S Gormezano; Gabriela R V Ferreira; Gabriela N Leal; Alessandro Lianza; Juliana C O A Ferreira; Rosa M R Pereira; Nadia E Aikawa; Maria Teresa Terreri; Claudia S Magalhães; Simone Appenzeller; Maria Carolina Dos Santos; Silvana B Sachetti; Claudio A Len; Gecilmara S Pilleggi; Simone Lotufo; Eloisa Bonfá; Clovis A Silva
Journal:  Pediatr Cardiol       Date:  2016-11-08       Impact factor: 1.655

2.  Lung involvement in children with newly diagnosed rheumatic diseases: characteristics and associations.

Authors:  Hua Huang; Yabin Hu; Yufen Wu; Fei Ding; Xuemei Xu; Yingying Jin; Yanliang Jin; Yixiao Bao
Journal:  Pediatr Rheumatol Online J       Date:  2022-08-20       Impact factor: 3.413

3.  Isolated acute lupus pneumonitis as the initial presentation of systemic lupus erythematosus in an 8-year-old girl.

Authors:  Tuğba Şişmanlar Eyüboğlu; Ayşe Tana Aslan; Yeşim Özdemir; Deniz Gezgin Yıldırım; Necla Buyan; Öznur Boyunağa
Journal:  Auto Immun Highlights       Date:  2018-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.